| Factor Information | |
|---|---|
| Data ID | 859 |
| Factor | Predischarge TTE-- Systemic ventricle dysfunction |
| Description | Adults with congenital heart disease (ACHD) undergoing systemic atrioventricular valve (SAVV) surgery are a complex, understudied population |
| Biomarker | NA |
| Classification | A7 (clinical factor - outcome) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | We assessed midterm outcomes and prognostic factors in ACHD undergoing SAVV surgery |
| p Value | <0.01 |
| Conclusion | Predischarge echocardiography revealed minimal regurgitation or stenosis; regurgitation was significantly greater in the AVSD group compared to other groups. Systemic ventricular dysfunction remained unchanged in the ccTGA group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 486 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | AVSD/ccTGA/MS, MR |
| Reference | |
|---|---|
| PMID | 28520541 |
| Year | 2017 |
| Title | Outcomes and Prognostic Factors for Adult Patients With Congenital Heart Disease Undergoing Primary or Reoperative Systemic Atrioventricular Valve Surgery. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | retrospective cohort study | |
| Region | New York, USA | |
| Method | retrospective evaluation | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | SAVV surgery | |
| Group | AVSD(Treatment) | Congenital MS/MR(Control) |
| Number | 1(total:15) | 6(total:14) |
| Age | 30.0 ± 8.7 years | 36.7 ± 11.4 years |
| Gender (Male: Female) | 5:10 (total) | 8:6 (total) |
| Marker Level | 0.08 | 0.55 |
